Showing results (361-370 of 582) with videos related to
Sort By:
Pageof 59
Circulation|April 17, 2008
Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitusMichael Davidson, Peter M Meyer, Steven Haffner, et al.Schizophrenia Research|October 23, 2015
A population-based longitudinal study of suicide risk in male schizophrenia patients: Proximity to hospital discharge and the moderating effect of premorbid IQMark Weiser, Ori Kapra, Nomi Werbeloff, et al.Expert Review of Anticancer Therapy|March 19, 2020
Update on optimal treatment for metastatic colorectal cancer from the AGITG expert meeting: ESMO congress 2019David K Lau, Matthew Burge, Amitesh Roy, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 25, 2019
Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancerIan Chau, Dung T Le, Patrick A Ott, et al.The Oncologist|June 2, 2018
Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open-Label, Phase I Trial (JVDF)Hendrik-Tobias Arkenau, Juan Martin-Liberal, Emiliano Calvo, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 4, 2019
Correction to: Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancerIan Chau, Dung T Le, Patrick A Ott, et al.British Journal of Haematology|March 22, 2003
Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphomaIan Chau, Mark Harries, David Cunningham, et al.Schizophrenia Bulletin|January 29, 2020
Network Analysis Indicates That Avolition Is the Most Central Domain for the Successful Treatment of Negative Symptoms: Evidence From the Roluperidone Randomized Clinical TrialGregory P Strauss, Farnaz Zamani Esfahlani, Hiroki Sayama, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 5, 2016
The association between premorbid cognitive ability and social functioning and suicide among young men: A historical-prospective cohort studyMark Weiser, Daphna Fenchel, Nomi Werbeloff, et al.Cancers|October 17, 2019
Outcomes of Patients with Early Onset Colorectal Cancer Treated in a UK Specialist Cancer CenterAlexandros Georgiou, Shelize Khakoo, Penelope Edwards, et al.Pageof 59